India Recovers $26.6 Million From Drug Makers Over Price Limits
This article was originally published in PharmAsia News
Executive Summary
India's drug-pricing agency says it has recovered $26.6 million from drug makers who sold their wares in unapproved dosages and strengths. The National Pharmaceutical Pricing Authority said it has sent notices to 555 pharmaceuticals accusing them of changing their brands to skirt the government's price caps. Drug makers say any changes they have made were in compliance with rules of the drug controller general of India, which is charged with regulating the quality of drugs. The head of the Indian Pharmaceutical Alliance said the changes made by its members were to improve the efficacy of the drugs. (Click here for more